EA200300768A1 - Фармацевтическая композиция, содержащая циталопрам - Google Patents

Фармацевтическая композиция, содержащая циталопрам

Info

Publication number
EA200300768A1
EA200300768A1 EA200300768A EA200300768A EA200300768A1 EA 200300768 A1 EA200300768 A1 EA 200300768A1 EA 200300768 A EA200300768 A EA 200300768A EA 200300768 A EA200300768 A EA 200300768A EA 200300768 A1 EA200300768 A1 EA 200300768A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cytalopra
pharmaceutical composition
composition containing
pharmaceutically acceptable
citalopram
Prior art date
Application number
EA200300768A
Other languages
English (en)
Other versions
EA005596B1 (ru
Inventor
Кен Лильегрен
Пер Хольм
Original Assignee
Х.Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х.Лундбекк А/С filed Critical Х.Лундбекк А/С
Publication of EA200300768A1 publication Critical patent/EA200300768A1/ru
Publication of EA005596B1 publication Critical patent/EA005596B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Твердая единичная дозированная лекарственная форма, содержащая циталопрам и получаемая способом, включающим стадию, на которой основание циталопрама или его фармацевтически приемлемую соль и, необязательно, фармацевтически приемлемые эксципиенты подвергают роликовому уплотнению.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300768A 2001-01-05 2002-01-03 Твёрдая лекарственная форма, включающая циталопрам EA005596B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100016 2001-01-05
PCT/DK2002/000003 WO2002053133A1 (en) 2001-01-05 2002-01-03 Pharmaceutical composition containing citalopram

Publications (2)

Publication Number Publication Date
EA200300768A1 true EA200300768A1 (ru) 2003-10-30
EA005596B1 EA005596B1 (ru) 2005-04-28

Family

ID=8159961

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300768A EA005596B1 (ru) 2001-01-05 2002-01-03 Твёрдая лекарственная форма, включающая циталопрам

Country Status (22)

Country Link
US (1) US20040058989A1 (ru)
EP (1) EP1351667A1 (ru)
JP (1) JP2004517111A (ru)
KR (1) KR20030070088A (ru)
CN (1) CN1484523A (ru)
AU (1) AU2001100195B4 (ru)
BG (1) BG108034A (ru)
BR (1) BR0206272A (ru)
CA (1) CA2358356A1 (ru)
CZ (1) CZ20032119A3 (ru)
EA (1) EA005596B1 (ru)
HR (1) HRP20030546A2 (ru)
HU (1) HUP0302531A3 (ru)
IL (1) IL156547A0 (ru)
IS (1) IS6857A (ru)
MX (1) MXPA03005965A (ru)
NO (1) NO20033073D0 (ru)
PL (1) PL362358A1 (ru)
SK (1) SK9912003A3 (ru)
WO (1) WO2002053133A1 (ru)
YU (1) YU54503A (ru)
ZA (1) ZA200304860B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
AU2004222339A1 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
NO20033073L (no) 2003-07-04
HUP0302531A3 (en) 2007-06-28
PL362358A1 (en) 2004-10-18
IL156547A0 (en) 2004-01-04
CA2358356A1 (en) 2002-01-20
BR0206272A (pt) 2003-12-30
AU2001100195A4 (en) 2001-08-16
WO2002053133A1 (en) 2002-07-11
AU2001100195B4 (en) 2001-12-20
HRP20030546A2 (en) 2005-06-30
EP1351667A1 (en) 2003-10-15
US20040058989A1 (en) 2004-03-25
CN1484523A (zh) 2004-03-24
HUP0302531A2 (hu) 2003-11-28
ZA200304860B (en) 2004-06-30
BG108034A (bg) 2005-02-28
KR20030070088A (ko) 2003-08-27
SK9912003A3 (en) 2003-12-02
CZ20032119A3 (en) 2004-03-17
EA005596B1 (ru) 2005-04-28
IS6857A (is) 2003-06-23
YU54503A (sh) 2006-05-25
NO20033073D0 (no) 2003-07-04
JP2004517111A (ja) 2004-06-10
MXPA03005965A (es) 2003-09-05

Similar Documents

Publication Publication Date Title
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
EE05104B1 (et) Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
BRPI0414539A (pt) composto, composição farmacêutica, e, uso de um composto
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
GEP20074047B (en) Pramipexole once-daily dosage form
NO20024891D0 (no) Farmasöytiske sammensetninger
EA200300183A1 (ru) Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
EA200400530A1 (ru) Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин"
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
TNSN05203A1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
EA200300247A1 (ru) Фармацевтическая композиция, содержащая циталопрам
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
EA200300768A1 (ru) Фармацевтическая композиция, содержащая циталопрам

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU